Fluxin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fluxin

What is Fluxin? Defining the Active Ingredient and Classification

Property Description
Active ingredient Flucloxacillin
Form Capsules, Oral suspension, Injection
Pharmacological class Beta-lactam antibiotic (Isoxazolyl Penicillin)
General purpose Elimination of susceptible Bacterial infections
Origin Semisynthetic

Fluxin is a prescription-only medicine whose sole active component is Flucloxacillin, which is clinically recognized as a potent Beta-lactam antibiotic. The compound is defined as a semisynthetic penicillin; this means it is chemically derived from the core penicillin structure yet is structurally modified to possess superior properties. Fluxin is a single-ingredient product and is available in various pharmaceutical preparations to facilitate both oral administration via capsules or oral suspension, as well as parenteral delivery through injection.


How Does Flucloxacillin Differ from Standard Penicillin?

Flucloxacillin possesses a crucial structural feature known as penicillinase resistance, enabling it to remain active against bacteria that produce deactivating enzymes. This resistance to the beta-lactamase enzyme is the primary differentiator when compared to earlier generations of standard penicillins which are often rendered inactive by common bacterial defenses. This engineered stability classifies Flucloxacillin as an Isoxazolyl Penicillin acting as a bactericidal agent against pathogens known for their ability to break down the antibiotic, particularly certain Staphylococcal infections.


The General Purpose of This Bactericidal Agent

The general therapeutic purpose of Fluxin is the swift and active elimination of susceptible bacterial infections within the body, thereby aiding in the resolution of systemic illnesses. Flucloxacillin achieves this by targeting the integrity of the bacterial outer layer through the Inhibition of bacterial cell wall synthesis, a destructive action that confirms its categorization as a bactericidal agent. This mechanism is effective against penicillinase-producing organisms and provides a comprehensive pharmacological strategy for resolving deep-seated or widespread infections caused by vulnerable microbial strains.

What side effects are possible with Fluxin?

Possible Side Effects and Safety Information

The safety profile of Fluxin (Flucloxacillin) is formally documented in regulatory sources, which classify potential adverse reactions based on their frequency and the physiological system affected.

Common reactions, which may affect up to 1 in 10 people, are generally mild and involve Gastrointestinal disorders, such as diarrhoea and nausea. Reactions classified as Uncommon, affecting up to 1 in 100 people, typically include certain Skin and subcutaneous tissue disorders, such as a rash or itching.


Serious Adverse Reactions and Safety Constraints

Reactions classified as Very Rare (may affect up to 1 in 10,000 people) include critical events related to the Immune system disorders and Hepatobiliary disorders.

Category Documented Reactions
Immune Anaphylaxis, Severe Cutaneous Adverse Reactions (SJS, TEN)
Hepatobiliary Hepatitis, Cholestatic Jaundice

The onset of hepatic reactions may be delayed, appearing several weeks after treatment has been stopped, and are reported more frequently following prolonged use. The medicine is Contraindicated in individuals with a known beta-Lactam hypersensitivity or a history of Flucloxacillin-associated jaundice or liver dysfunction. Older adults and patients with pre-existing severe hepatic impairment are identified in official labeling as groups requiring particular caution. For prolonged treatments, regular monitoring of hepatic and renal functions is recommended by regulatory authorities.

Overdose and Emergency Response

Overdose and when to seek help

Documented Manifestations and Severe Outcomes

Overdose presentations with Fluxin (Flucloxacillin) are officially documented to include common effects such as nausea and diarrhoea. At very high parenteral doses, more serious manifestations can occur, particularly affecting the central nervous system (CNS) with convulsions and the metabolic system with electrolyte disturbances, including potentially life-threatening hypokalaemia.

The regulatory profile notes the risk of neurotoxicity and nephrotoxicity, especially in individuals with impaired renal function. A specific risk highlighted is High Anion Gap Metabolic Acidosis (HAGMA) when the medicine is combined with paracetamol in vulnerable patients. Furthermore, regulatory sources specify that special caution must be taken with newborns/neonates receiving high doses due to the risk of hyperbilirubinaemia and potential kernicterus.

Emergency Actions Required

For any suspected overdose, official guidance explicitly mandates that you seek immediate medical attention. This action is required due to the documented potential for serious neurological and metabolic complications. The documented management approach is primarily focused on symptomatic and supportive treatment; urgent medical care is necessary for severe disturbances.

Therapeutic Uses of Fluxin

What Fluxin Treats: Main Uses and Benefits

Fluxin is generally applied in situations involving certain distressing symptoms and conditions caused by susceptible bacterial infections. Its therapeutic value contributes to easing the overall symptom load across major areas of patient discomfort and clinical risk. The medicine is indicated for multiple types of bacterial infections.

The medication is commonly used across conditions presenting with acute episodes, such as cellulitis, abscesses, and infected wounds. It is also considered relevant in contexts involving heightened systemic burden related to severe infections, including osteomyelitis and septicaemia. It is applied when supportive symptom management is appropriate, often as prophylaxis to avert post-operative infection in high-risk procedures.

Quick Fact: Support for Localized Discomfort Fluxin is commonly used to help with symptoms that interfere with daily comfort, particularly those related to the swelling, heat, and pain associated with acute skin infections.

Regulatory References

  1. HPRA product overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Fluxin

Official regulatory documents define absolute contraindications and strict population-based restrictions for the use of Fluxin (Flucloxacillin).


Eligibility Scope

Population Status Regulatory Classification (Official Statements)
Contraindicated Patients with known hypersensitivity to Flucloxacillin, penicillin, or any beta-lactam antibiotic (e.g., cephalosporins). The medicine is also strictly contraindicated in patients with a prior history of flucloxacillin-associated jaundice or hepatic dysfunction [Source 1.2, 1.4].
Conditional Use Neonates and premature infants require special caution due to the risk of hyperbilirubinemia. Patients ge 50 years of age or those with existing hepatic dysfunction should use the medicine with caution [Source 1.1, 1.2].
Restricted Eligibility Use requires consideration of dose adjustment in patients with severe renal impairment (CLCR < 10 mL/min) [Source 2.3]. The medicine should only be used in pregnancy or lactation when the potential benefits outweigh the potential risks [Source 4.3].
Eligible Populations Adults, adolescents, and children above a minimum specified age/weight are generally eligible under standard guidelines [Source 2.1, 2.2].

Connection to the Overall Eligibility Profile

Regulatory agencies define eligibility by establishing prohibitions for those with immunological history (allergy) or past drug-induced organ injury. For populations with impaired renal or hepatic function, or at the extremes of age, eligibility is conditional, requiring special caution or dose-interval consideration as explicitly stated in the official prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Fluxin (Flucloxacillin) is defined by its effects on drug elimination and potential for pharmacodynamic opposition, as documented by regulatory authorities.

Official Interaction Statements

Interacting Substance Officially Documented Interaction Pattern
Probenecid and Sulfinpyrazone Reduce the excretion of Flucloxacillin by decreasing renal tubular secretion, resulting in increased Flucloxacillin plasma concentration.
Methotrexate Flucloxacillin reduces the excretion of Methotrexate, increasing the risk of toxicity.
Warfarin Associated with changes in the International Normalized Ratio (INR); monitoring is required.
Paracetamol (Acetaminophen) Increased risk of high anion gap metabolic acidosis (HAGMA), with caution advised for patients with severe renal impairment or sepsis.
Bacteriostatic Drugs May interfere with the bactericidal action of Flucloxacillin.
Oral Typhoid Vaccine May be inactivated by Flucloxacillin.

Timing-Based Constraint

Administration with food significantly reduces the AUC and Cmax of Flucloxacillin. Regulatory documents advise taking the medicine on an empty stomach to mitigate this exposure reduction.

Mechanism of Action

Flucloxacillin functions as a bactericidal agent by engaging distinct mechanistic domains focused exclusively on initiating the destruction of susceptible microbial targets through irreversible structural interference. This action is dependent on specific molecular interactions with the pathogen, not with human physiological systems.


Irreversible Inhibition of Cell Wall Construction

This domain details the core destructive process that leads to microbial cell death. Flucloxacillin irreversibly acts on Penicillin-Binding Proteins (PBPs), which are bacterial enzymes essential for the final peptidoglycan cross-linkage that grants the cell wall its rigidity. By forming a permanent covalent bond with these enzymes, the drug halts the construction of the structural barrier, thereby initiating a rapid, self-destructive cascade known as cell lysis, which physiologically results in the microbial cell rupture.


Targeted Resistance to Bacterial Defense Mechanisms

This domain details how the drug's structure confers resistance to certain bacterial defense enzymes. Flucloxacillin possesses a strategically placed isoxazolyl side chain that creates a steric hindrance barrier. This modification prevents bacterial beta-Lactamase enzymes from deactivating the critical beta-lactam ring, which allows the molecule to maintain its inhibitory activity and execute its cell wall inhibition mechanism.

Dosage and Administration Information

Fluxin (Flucloxacillin) is administered via Oral routes (capsules or suspension) and Parenteral routes, specifically Intravenous (IV) or Intramuscular (IM) injection. For specific deep-seated contexts, local injection routes like Intrapleural or Intra-articular may be used.

Standard adult oral dosing ranges from 250 mg to 500 mg. The maximum dose for severe systemic infections may reach up to 8 grams per day when administered parenterally, with all doses required to be divided throughout the day. The primary frequency pattern is four times a day, meaning doses should be administered at approximately six-hour intervals to maintain consistent therapeutic levels.

A crucial administration requirement for the oral form is that it must be taken on an empty stomach—either 60 minutes before a meal or 2 hours after a meal—to facilitate optimal absorption. For injectable forms, preparation involves dilution, and IV injections must be administered slowly over a period of 3 to 4 minutes.

Usage rules are modified for certain populations. Patients with severe renal impairment (creatinine clearance < 10 mL/min) require a dose adjustment, limiting the maximum dose to 1 gram every 8 to 12 hours. If a dose is missed, it should be taken immediately unless the next dose is due, as doses must not be doubled. Completion of the entire prescribed course is mandated as part of the usage protocol.

Recent Clinical Evidence

Fluxin: Recent Clinical Evidence

This section describes the types of clinical studies conducted for flucloxacillin, focusing on the scope of the research and what findings suggest about group patterns, while maintaining a clear statement of limitations and uncertainties.

Evidence for Skin and Soft Tissue Infections (SSTIs)

Research exploring flucloxacillin's use in management regimens for common infections like cellulitis and abscesses comes from Randomized Controlled Trials and Systematic Reviews involving adults and children. Studies measured clinical cure rates and the time to clinical response, which are outcomes related to acute changes in symptoms like swelling or pain. Comparative trials described patterns where the outcomes measured for flucloxacillin were observed to be within the pre-defined margin of difference when evaluated against certain alternatives. Research exploring the value of adding a second antibiotic for uncomplicated cellulitis often reported measured outcomes that were no different than those reported for flucloxacillin alone.

Evidence for Systemic and Deep-Seated Infections

For more serious, systemic infections such as osteomyelitis (bone infection) and septicaemia (bloodstream infection), the evidence is largely derived from Observational Cohort Studies and Retrospective Reviews. These studies monitored long-term outcomes reflecting systemic imbalance, including mortality rates and the relapse or recurrence of infection over extended periods. Limited prospective trials directly compare flucloxacillin to all alternative agents for long-term treatment of these conditions, meaning the reliance on observational data means that results apply only to the populations studied.

Research Gaps and Areas of Uncertainty

The research landscape contains several areas where certainty remains low. Comparative evidence is lacking in large, definitive Randomized Controlled Trials for serious infections like osteomyelitis. The data for certain groups remain insufficient, and the evidence quality varies across studies due to inconsistency in how researchers define key endpoints like "clinical cure."

Key Studies & References

  1. Cellulitis and erysipelas: antimicrobial prescribing (NICE Guideline NG141)
  2. Principles of Antibiotic Prophylaxis in Surgery

Frequently Asked Questions (FAQ)

Common questions about Fluxin (FAQ)


Q: How quickly should I expect to feel any effects from Fluxin?

Official patient information often suggests that individuals taking Fluxin may begin to notice an improvement in their symptoms within approximately two to five days of starting the treatment. The expected time for clinical response may vary depending on the type and severity of the infection being addressed.


Q: Does taking Fluxin with food change how it works?

Yes, official prescribing information advises on this timing. Taking Fluxin with food significantly reduces the absorption of the medicine into the bloodstream. This reduction in the medicine's level can affect the level available to fight the infection and is why regulatory documents advise taking the medicine on an empty stomach.


Q: What is the process for adjusting the dose of Fluxin?

Regulatory documents mention that dosage adjustments are specifically required for individuals diagnosed with severe renal impairment (a serious kidney condition) and may be needed for severe infections. However, the general process for changing a dose, beyond these specific conditions, is not described in the general patient information provided in the label.


Q: What are the most common reasons why patients are advised to stop taking Fluxin?

Official documents indicate that the medicine must be discontinued immediately if a patient develops severe, life-threatening allergic reactions, such as anaphylaxis or certain severe skin reactions (like Stevens-Johnson syndrome or Toxic Epidermal Necrolysis). Otherwise, patients are instructed to complete the entire duration of the treatment as prescribed.


Q: Can Fluxin cause stomach upset or digestive issues?

Yes, official safety data indicates that Gastrointestinal disorders are a common category of side effects reported with Fluxin. These frequently reported reactions include nausea, vomiting, diarrhoea, and general stomach upset. If these symptoms become bothersome, official guidance recommends consulting a healthcare provider.


Q: Is Fluxin safe to use for elderly patients?

Official labeling advises that caution is recommended when Fluxin is used in patients over the age of 50 or those who have underlying health conditions. This group may require particular caution due to a potential increased risk for specific serious adverse reactions, such as those involving the liver.


Q: What kind of studies support the use of Fluxin?

Official research summaries indicate that evidence for Fluxin is drawn from several types of clinical studies. These include Randomized Controlled Trials (RCTs) for common conditions like skin infections, and Observational Studies or Retrospective Reviews for more serious, systemic infections. This variety of research supports its use across its authorized applications.


Q: How does Fluxin work differently than older classes of medicines for this condition?

Fluxin belongs to a modified group of penicillin known as an Isoxazolyl Penicillin. Its chemical structure includes a special feature that grants it resistance to beta-Lactamase enzymes produced by certain bacteria. This resistance is the primary differentiator, allowing it to remain active against bacteria that produce these deactivating enzymes, unlike older standard penicillins.


Q: If I am pregnant or planning to be, what do official sources say about Fluxin use?

According to official regulatory documents, the use of Fluxin during pregnancy or while lactating should only occur when a healthcare provider determines that the potential therapeutic benefits for the patient outweigh any potential risks. The label emphasizes that use must be decided based on a review of potential risks versus benefits.


Q: What is the risk of an allergic reaction to Fluxin?

Allergic reactions, ranging from mild skin issues to severe reactions like anaphylaxis, are documented adverse events. Official patient safety information highlights that these reactions are considered more likely in individuals who have a known history of hypersensitivity to penicillin or any beta-lactam antibiotics.


Q: Is Fluxin used in children or adolescents under specific circumstances?

Official prescribing information states that the use of Fluxin in neonates and premature infants requires special caution. This caution is necessary due to the potential risk of hyperbilirubinemia (a type of jaundice) and the possible attainment of high medicine levels in their serum.


Q: Does Fluxin cause drowsiness or tiredness during the day?

Official documents list tiredness and dizziness as reported adverse reactions that can occur while using the medicine. Because of these potential effects, official patient labels indicate that caution is necessary when driving or operating heavy machinery until you are aware of how Fluxin affects you.


Q: Are there common long-term side effects associated with Fluxin?

Severe liver reactions, such as Hepatitis and Cholestatic Jaundice, are documented in regulatory sources and may be associated with prolonged use. Importantly, the onset of these hepatic reactions can be delayed, with some cases reported several weeks or even up to two months after treatment has been completed.


Q: Can Fluxin affect my mood or personality?

Regulatory labels include reports of nervous system disorders (CNS effects), which include reported reactions like dizziness and convulsions. While these do not explicitly list changes to mood or personality, official information indicates that monitoring for any changes in nervous system function may be necessary.


Q: Is it necessary to take Fluxin at the exact same time every day?

Regulatory and patient information advises taking the prescribed doses at evenly spaced intervals throughout the day. For medicines prescribed four times a day, this means taking doses approximately six hours apart. This spacing is intended to help maintain consistent levels of the medicine in the body.


Q: Is it possible for Fluxin to affect my sleep patterns?

Official side effect reports mention CNS-related adverse effects such as dizziness and convulsions. While there is no explicit listing for 'insomnia' or 'vivid dreams' in the common side effects, some effects on the nervous system have been reported.


Q: Is Fluxin generally prescribed for short-term or long-term use?

Fluxin is primarily used as an acute treatment (short-term course). However, official research and guidelines note that the management of certain serious conditions, like bone infections (osteomyelitis), may involve extended treatment courses and require long-term monitoring. Short-term use is usually intended to clear the bacterial infection.


Q: What should I do if a side effect seems mild but doesn't go away?

Official patient information states that continued use is generally advised, but consulting a healthcare professional is recommended if a side effect is still bothersome or does not go away over time.


Q: Are there any specific laboratory tests required before starting Fluxin?

The official product label specifically requires the regular monitoring of hepatic (liver) and renal (kidney) functions for individuals who are receiving prolonged treatment with Fluxin. However, the label does not explicitly mandate specific tests before beginning a standard course of therapy.


Q: Why do official documents mention potential weight changes with Fluxin?

Official patient information mentions that factors like patient weight are considered by a prescribing doctor when deciding the correct dose and duration for injectable forms of the medicine. Weight is mentioned as a factor considered by the prescribing doctor when determining the appropriate dose, but it is not listed as an associated side effect.


Q: Is it true that Fluxin has a 'black box' warning from the FDA or similar agency?

According to general drug safety information, a specific Black Box Warning—the most stringent safety warning issued by the FDA in the United States—is not identified for Flucloxacillin. However, like all prescription medicines, the drug carries other serious safety warnings and contraindications detailed in the official prescribing information.


Q: Is Fluxin known to cause dry mouth or changes in taste?

Adverse event reports included in official documentation have reported a bad or altered taste in the mouth among the side effects experienced by patients. Dry mouth has also been reported as an adverse event.


Q: Does Fluxin interact with alcohol consumption?

Based on official guidance, there is no known interaction between Fluxin and alcohol consumption. Official patient information explicitly states that it is generally permissible to drink alcohol while taking this medicine.


Q: Are there any documented cases of overdose with Fluxin?

Official patient safety information provides specific guidance on what steps should be taken if an individual, including a child, accidentally takes more than the recommended dose of Fluxin. This guidance is in place as a safety protocol.


Q: What should I do if I feel dizzy or lightheaded while taking Fluxin?

Dizziness is a reported adverse effect. Official warnings state that patients should not drive or operate machinery if they experience this reaction. If the dizziness persists or becomes severe, consulting a healthcare provider is recommended.


Q: Can I crush or split Fluxin tablets?

Official patient information notes that capsules can be opened and the contents mixed with liquid or soft food for easier swallowing. Furthermore, certain film-coated tablets can be crushed or dispersed in liquid, though the advice may vary by specific formulation, particularly those that are modified-release.


Q: Does Fluxin affect fertility?

Official patient safety information states that Fluxin does not stop any type of contraception working. However, official documents do not provide general information or conclusions regarding the medicine's effect on a patient’s overall ability to conceive.


Q: Why is Fluxin sometimes called a 'selective' medicine?

Fluxin has a narrow spectrum of activity, and its mechanism is considered selective because its primary target is the cell wall of susceptible Gram-positive bacteria, such as Staphylococcus aureus. This action differentiates it from broad-spectrum antibiotics that target a wider range of bacteria.


Q: What are the rules regarding driving while taking Fluxin, according to official warnings?

Official warnings state that the medicine does not generally cause problems with driving. However, because dizziness is a documented side effect, the official label advises that patients should not drive or operate machinery if they experience this particular reaction.


Q: Are there any official recommendations about gradually discontinuing Fluxin?

Regulatory instructions emphasize the importance of completing the entire prescribed course to ensure the infection is fully resolved. Discontinuation is only addressed in the context of avoiding abrupt cessation if the full course has not yet been completed, but not as a standard tapering recommendation.

How should Fluxin be stored and disposed of?

The storage of Fluxin (Flucloxacillin) is dependent on the product formulation.

Storage Conditions

Capsules and Dry Powder: The product must be stored in the original package, protected from light and moisture, at a temperature below 25 C or 30 C.

Reconstituted Oral Solution: The prepared liquid must be stored under refrigeration (2 C to 8 C) and must not be frozen. This solution has a limited stability period and must be used within 7 to 14 days after reconstitution, depending on the specific label.

Child Safety and Disposal

All Fluxin products must be stored out of the sight and reach of children. Unused or expired medicine should not be thrown away via wastewater or household waste. Disposal must be conducted in accordance with local requirements, typically by returning it to a pharmacist.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fluxin found in:

A-Z Index: